Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis. [electronic resource]
Producer: 20200504Description: 297-310 p. digitalISSN:- 1365-2141
- Adolescent
- Adult
- Aged
- Antibodies, Monoclonal, Humanized -- adverse effects
- Atypical Hemolytic Uremic Syndrome -- drug therapy
- Child
- Child, Preschool
- Complement Inactivating Agents -- adverse effects
- Databases, Factual
- Fatigue -- chemically induced
- Female
- Fever -- chemically induced
- Hemoglobins -- deficiency
- Hemoglobinuria, Paroxysmal -- drug therapy
- Humans
- Infant
- Infant, Newborn
- Male
- Meningococcal Infections -- chemically induced
- Middle Aged
- Opportunistic Infections -- chemically induced
- Pharmacovigilance
- Pregnancy
- Pregnancy Complications -- drug therapy
- Pregnancy Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.